2022, Number 3
Use of platelet lysate in the treatment of epidermal toxic necrolysis: a case presentation
Language: Spanish
References: 18
Page: 1-11
PDF size: 356.74 Kb.
ABSTRACT
Introduction: In recent years there has been an extraordinary impulse of regenerative medicine, the use of platelets for this purpose has been used in different medical specialties. The most feared of the dermatological complications is toxic epidermal necrolysis, of which up to 4 cases per million inhabitants occur annually, with a mortality that sometimes reaches up to 70%.Objective: To describe the use of platelet lysate as regenerative therapy in the treatment of epidermal toxic necrolysis.
Case presentation: We present a case of a 53-year-old patient with a pathological history of arterial hypertension, diabetes mellitus, multiple myeloma and chronic renal insufficiency, who was admitted with a diagnosis of community acquired pneumonia and acute chronic renal insufficiency, for which multiple treatments. She began with erythematous, non-pruritic, and then bullous skin lesions that are easily debrided into large areas of denuded skin, scattered throughout the body. A toxic epidermal necrolysis was diagnosed, the usual treatment measures were started and the allogeneic platelet lysate was used topically.
Conclusions: A favorable response was observed, with cutaneous re-epithelialization of the skin, although the patient's underlying disease and its comorbidities died.
REFERENCES
. Hernández Hernández A, Anillo Badía R. Medicina regenerativa y medicina del deporte, una fructífera integración: introducción y avances en Cuba. Rev Cubana Hematol Inmunol Hemoter. 2016 [acceso 01/03/2021];32(3). Disponible en: Disponible en: http://www.revhematologia.sld.cu/index.php/hih/article/view/434 3.
Hernández Ramírez P, Artaza Sánz H, Aparicio Suárez JL, Cruz Tamayo F, Díaz Díaz AJ. Impact of the regenerative medicine in Angiology. Cuban experience. Rev Cubana Angiol Cir Vasc. 2017 [acceso 07/02/2021];18(1):3-18. Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1682-00372017000100002&lng=es 4.
. Pérez-Borrego A, Hernández-Aréchaga G, Fernández Delgado N, González-Iglesias AI. Lisado plaquetario y células mononucleares autólogas de la periodontitis crónica. Presentación de un caso. Rev haban cienc méd. 2017 [acceso 07/02/2022];16(2):189-98. Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1729-519X2017000200006&lng=es 6. .
. Peña Sisto Maritza, García Céspedes María Eugenia. Terapia periodontal regenerativa con hemocomponentes en Santiago de Cuba desde lo social y formativo. Rev Hum Med. Dic 2021 [acceso 07/02/2021];21(3):749-62. Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1727-81202021000300749&lng=es 7.
Misiara Álvarez AE, Ruiz Hernández I, García Güell A, Jiménez Ventosa Y, Torres Morales MB. Primer reporte de necrólisis epidérmica tóxica por antibiótico oral en Gambia. Rev Méd Electrón. 2017 [acceso: 07/02/2021];39(6). Disponible en: Disponible en: http://www.revmedicaelectronica.sld.cu/index.php/rme/article/view/1943/3649 9.
Blanco Guzmán S, Govín Gámez JF, Govín Gámez LG, Toledo Sánchez N, Cruz Sánchez PM, Santacruz C, et al. Pacientes con retardo de consolidación, infiltrados con lisado plaquetario autólogo. Rev Cubana Ortop Traumatol . 2018 [acceso 07/02/2021];32(2). Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-215X2018000200001&lng=es 13. .
. Piloto Tomes KM, Agüero Martínez MO, Blanco Guzmán S, Gámez Pérez A, Govin Gaméz JF. Autologous platelet lysate and its effectiveness in patients with epicondylitis. Rev cuba anestesiol reanim. 2021 [acceso 07/02/2021];20(3):e751. Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S172667182021000300004&lng=es 16. .
. Miquet Romero LM, Tamayo Carbón AM, Orozco Jaramillo MA, Sánchez Tavizón SP, Hernández Collado MC, Posada Ruiz DA. Lisado plaquetario homólogo como factor estimulante de la cicatrización en la zona donante de injertos. Rev Cubana Hematol Inmunol Hemoter. 2021 [acceso 07/02/2021];37(2):e1261. Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S086402892021000200005&lng=es 17.